Безопасен ли myristoyl dipeptide-13 при беременности?

Related ingredients

Frequently asked questions

Безопасен ли myristoyl dipeptide-13 при беременности?

No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR reproductive safety flags found, and no peer‑reviewed reproductive toxicity studies indicating concern. Regulatory sources do not list reproductive hazards for Myristoyl Dipeptide‑13 (ECHA Annex VI absent; CIR/SCCS no adverse opinions).

Безопасен ли myristoyl dipeptide-13 при грудном вскармливании?

No data or regulatory classification indicating lactation/breastfeeding transfer or effects. No peer‑reviewed evidence of systemic reproductive toxicokinetics relevant to breastfeeding; default regulatory stance is 'no flag'.

Безопасен ли myristoyl dipeptide-13 для кожи малыша?

No specific infant safety or developmental toxicity data found. As a lipophilic peptide (myristoyl‑modified), topical systemic absorption in adults is expected to be negligible (hence adult e=0), but infant skin has higher permeability and surface‑area‑to‑weight, so exposure score increased by +1 to reflect potentially higher measurable absorption in 0–3 yr olds. No data indicating increased hazard or mechanism in infants.

Как VeriMom оценивает myristoyl dipeptide-13?

VeriMom оценивает myristoyl dipeptide-13 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы myristoyl dipeptide-13 при беременности?

См. наш список безопасных альтернатив myristoyl dipeptide-13 с аналогичной функцией и классификацией без известных рисков.